XML 76 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (USD $)
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Revenues $ 14,329,889 $ 10,050,086
Cost of revenues 11,949,124 8,646,687
Gross profit 2,380,765 1,403,399
Research and development 10,451,070 7,720,748
Selling, general, and administrative 22,315,346 27,687,162
Operating Expenses 32,766,416 35,407,910
Operating loss (30,385,651) (34,004,511)
Other income (expense):    
Other (expense) income, net (4,314,228) 2,085,870
Interest expense (1,576,975) (2,647,692)
Nonoperating Income (Expense), Total (5,891,203) (561,822)
Loss from operations before provision for income taxes and noncontrolling interests (36,276,854) (34,566,333)
Provision (benefit) for income taxes (175,533) 0
Net loss from continuing operations (36,101,321) (34,566,333)
Loss from discontinued operations - net (30,267,990) (22,016,524)
Net loss (66,369,311) (56,582,857)
Less - loss from continuing operations attributable to noncontrolling interests (287,181) (299,789)
Less - loss from discontinued operations attributable to noncontrolling interests (12,312,646) (9,148,599)
Net loss attributable to NeoStem, Inc. (53,769,484) (47,134,469)
Warrant inducements (1,012,819) 0
Preferred dividends (528,023) (639,765)
Amounts Attributable to NeoStem, Inc. common shareholders:    
Loss from continuing operations (35,814,140) (34,266,544)
Loss from discontinued operations - net of taxes (17,955,344) (12,867,925)
Preferred dividends (528,023) (639,765)
Net loss attributable to NeoStem, Inc. common stockholders $ (55,310,326) $ (47,774,234)
Basic and diluted (loss) per share attributable to:    
Continuing operations $ (0.26) $ (0.39)
Discontinued operations $ (0.13) $ (0.15)
NeoStem, Inc. common stockholders $ (0.40) $ (0.54)
Weighted average common shares outstanding 138,419,965 88,598,696